Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloid Light-chain Amyloidosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT07626476
What this trial is testing

Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis

Who this might be right for
Relapsed/Refractory Light Chain AmyloidosisAL AmyloidosisSystemic Light Chain Amyloidosis
Beijing Boren Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07039578
What this trial is testing

Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis

Who this might be right for
Primary Light-Chain Amyloidosis
Keymed Biosciences Co.Ltd 90
Testing effectiveness (Phase 2)UnknownNCT05066607
What this trial is testing

Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy

Who this might be right for
AL Amyloidosis
Intergroupe Francophone du Myelome 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT05451771
What this trial is testing

Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis

Who this might be right for
AL Amyloidosis
Columbia University 53
Testing effectiveness (Phase 2)Study completedNCT01083316
What this trial is testing

Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis

Who this might be right for
Amyloidosis
Boston Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT02841033
What this trial is testing

Daratumumab for the Treatment of Patients With AL Amyloidosis

Who this might be right for
AL Amyloidosis
Boston Medical Center 22
Not applicableStudy completedNCT02257905
What this trial is testing

Allo SCT in Amyloidosis Non-interventional Study

Who this might be right for
AL Amyloidosis
European Society for Blood and Marrow Transplantation 14
Not applicableLooking for participantsNCT06887283
What this trial is testing

Essen Amyloidosis Registry

Who this might be right for
Amyloidosis; SystemicAmyloidosis Cardiac
University Hospital, Essen 400
Not applicableStudy completedNCT01758042
What this trial is testing

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders

Who this might be right for
Chronic Kidney DiseaseAcute Myeloid Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)+14 more
Massachusetts General Hospital 10
Not applicableActive Not RecruitingNCT05879874
What this trial is testing

Prospective Evaluation of NfL as a Biomarker in ATTRv

Who this might be right for
Amyloidosis, Hereditary
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 40
Testing effectiveness (Phase 2)Study completedNCT05028374
What this trial is testing

COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies

Who this might be right for
Multiple MyelomaAL AmyloidosisChronic Lymphocytic Leukemia
Barbara Ann Karmanos Cancer Institute 119
Testing effectiveness (Phase 2)Study completedNCT00883623
What this trial is testing

A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis

Who this might be right for
Primary Amyloidosis
Heidelberg University 50
Testing effectiveness (Phase 2)Study completedNCT01510613
What this trial is testing

Pomalidomide and Dexamethasone (PDex) in AL Amyloidosis

Who this might be right for
Primary Amyloidosis of Light Chain Type
Fondazione IRCCS Policlinico San Matteo di Pavia 28
Testing effectiveness (Phase 2)Study completedNCT00224393
What this trial is testing

Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis

Who this might be right for
Primary Systemic Amyloidosis
The Cleveland Clinic 60
Not applicableStudy completedNCT04659798
What this trial is testing

Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice

Who this might be right for
Multiple MyelomaImmunoglobulin Light-chain Amyloidosis
Takeda 240
Not applicableLooking for participantsNCT06855121
What this trial is testing

The Norwegian Immunotherapy in Multiple Myeloma Study

Who this might be right for
Myeloma MultiplePlasma Cell LeukemiaAL Amyloidosis
St. Olavs Hospital 400
Testing effectiveness (Phase 2)Study completedNCT00298766
What this trial is testing

Open-Label Phase 1/2 Study of VELCADE for Injection in Patients With Light-chain (AL)-Amyloidosis

Who this might be right for
Amyloidosis
Millennium Pharmaceuticals, Inc. 70
Early research (Phase 1)Ended earlyNCT04115956
What this trial is testing

A Clinical Study of Melphalan Flufenamide (Melflufen) and Dexamethasone for Patients With Immunoglobulin Light Chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
Oncopeptides AB 6
Not applicableLooking for participantsNCT04924998
What this trial is testing

Clinical Study for AL-CM

Who this might be right for
Immunoglobulin Light Amyloidosis Cardiomyopathy
Second Affiliated Hospital, Zhejiang University, School of Medicine 400
Early research (Phase 1)Study completedNCT00006362
What this trial is testing

PS-341 in Treating Patients With Advanced Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Mayo Clinic
Next Page